The pharmacology of CP-154,526, a non-peptide antagonist of the CRH1 receptor: a review (Q34178687)

31 July 2017

1 reference

title

The pharmacology of CP-154,526, a non-peptide antagonist of the CRH1 receptor: a review (English)

1 reference

31 July 2017

The Pharmacology of CP-154,526, a Non-Peptide Antagonist of the CRH1 Receptor: A Review (English)

0 references

1 reference

Patricia A Seymour

1

1 reference

31 July 2017

Anne W Schmidt

2

1 reference

31 July 2017

David W Schulz

3

1 reference

31 July 2017

Patricia A. Seymour

1

0 references

Anne W. Schmidt

2

0 references

David W. Schulz

3

0 references

language of work or name

1 reference

1 January 2003

1 reference

CNS Neuroscience & Therapeutics

31 July 2017

7 June 2006

0 references

published in

1 reference

31 July 2017

9

1 reference

31 July 2017

1

1 reference

31 July 2017

57-96

1 reference

Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of corticotropin-releasing hormone receptors.

31 July 2017

1 reference

12 December 2020

Peripheral urocortin delays gastric emptying: role of CRF receptor 2

1 reference

12 December 2020

Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications

1 reference

12 December 2020

Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001.

1 reference

12 December 2020

Autoradiographic and in situ hybridization localization of corticotropin-releasing factor 1 and 2 receptors in nonhuman primate brain.

1 reference

12 December 2020

Is there a future for neuropeptide receptor ligands in the treatment of anxiety disorders?

1 reference

12 December 2020

In vitro pharmacological profile of nonpeptide CRF1 receptor antagonists, CRA1000 and CRA1001

1 reference

12 December 2020

The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety

1 reference

12 December 2020

Stress-induced behaviors require the corticotropin-releasing hormone (CRH) receptor, but not CRH.

1 reference

12 December 2020

Stress, corticotropin-releasing hormone, glucocorticoids, and the immune/inflammatory response: acute and chronic effects

1 reference

12 December 2020

Chronic administration of the non-peptide CRH type 1 receptor antagonist antalarmin does not blunt hypothalamic-pituitary-adrenal axis responses to acute immobilization stress.

1 reference

12 December 2020

Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor 1.

1 reference

12 December 2020

Functional, endogenously expressed corticotropin-releasing factor receptor type 1 (CRF1) and CRF1 receptor mRNA expression in human neuroblastoma SH-SY5Y cells

1 reference

12 December 2020

Characterisation using microphysiometry of CRF receptor pharmacology

1 reference

12 December 2020

Differential effects of two corticotropin-releasing factor antagonists on conditioned defeat in male Syrian hamsters (Mesocricetus auratus)

1 reference

12 December 2020

Corticotropin-releasing hormone receptors mediate consensus interferon-alpha YM643-induced depression-like behavior in mice

1 reference

12 December 2020

Role of corticotropin-releasing factor receptor-1 in opiate withdrawal

1 reference

12 December 2020

Corticotropin-releasing hormone-mediated neuroprotection against oxidative stress is associated with the increased release of non-amyloidogenic amyloid beta precursor protein and with the suppression of nuclear factor-kappaB

1 reference

12 December 2020

Effects of Corticotropin-Releasing Factor on Neuronal Activity in the Serotonergic Dorsal Raphe Nucleus

1 reference

12 December 2020

The role of afferents to the locus coeruleus in the handling stress-induced increase in the release of noradrenaline in the medial prefrontal cortex: a dual-probe microdialysis study in the rat brain

1 reference

12 December 2020

4-(1,3-Dimethoxyprop-2-ylamino)-2,7-dimethyl-8-(2, 4-dichlorophenyl)pyrazolo[1,5-a]-1,3,5-triazine: a potent, orally bioavailable CRF(1) receptor antagonist

1 reference

12 December 2020

The role of the CRH type 1 receptor in autonomic responses to corticotropin- releasing hormone in the rat

1 reference

12 December 2020

Effects of the CRF(1) receptor antagonist, CP 154,526, in the separation-induced vocalization anxiolytic test in rat pups.

1 reference

12 December 2020

Effects of a novel corticotropin-releasing-hormone receptor type I antagonist on human adrenal function

1 reference

12 December 2020

Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates

1 reference

12 December 2020

Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated

1 reference

12 December 2020

Role of corticotropin-releasing factor (CRF) receptors in the anorexic syndrome induced by CRF

1 reference

12 December 2020

Use of a dual firefly and Renilla luciferase reporter gene assay to simultaneously determine drug selectivity at human corticotrophin releasing hormone 1 and 2 receptors.

1 reference

12 December 2020

Peripheral administration of CRF and urocortin: effects on food intake and the HPA axis in the marsupial Sminthopsis crassicaudata.

1 reference

12 December 2020

Chronic administration of the selective corticotropin-releasing factor 1 receptor antagonist CP-154,526: behavioral, endocrine and neurochemical effects in the rat

1 reference

12 December 2020

The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats.

1 reference

12 December 2020

Corticotropin-releasing factor receptor type I mediates stress-induced relapse to opiate dependence in rats.

1 reference

12 December 2020

The discovery of 4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1 ,5-a]-pyrimidine: a corticotropin-releasing factor (hCRF1) antagonist

1 reference

12 December 2020

Effect of corticotropin releasing factor receptor 1 antagonist on extracellular norepinephrine, dopamine and serotonin in hippocampus and prefrontal cortex of rats in vivo

1 reference

12 December 2020

Effects of the CRH receptor antagonist CP-154,526 on intravenous cocaine self-administration in rats

1 reference

12 December 2020

A corticotropin releasing hormone receptor antagonist does not delay parturition in rats

1 reference

12 December 2020

Antalarmin blockade of corticotropin releasing hormone-induced hypertension in rats

1 reference

12 December 2020

Suppression of conditioned fear by administration of CRF receptor antagonist CP-154,526.

1 reference

12 December 2020

Peripheral corticotropin-releasing factor and stress-stimulated colonic motor activity involve type 1 receptor in rats

1 reference

12 December 2020

Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence.

1 reference

12 December 2020

Involvement of corticotropin-releasing factor in the retrieval process of fear-conditioned ultrasonic vocalization in rats.

1 reference

12 December 2020

Urocortin and corticotropin-releasing factor receptor expression in the human colonic mucosa

1 reference

12 December 2020

Role of CRF receptor 1 in central CRF-induced stimulation of colonic propulsion in rats

1 reference

12 December 2020

Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal

1 reference

12 December 2020

Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors

1 reference

12 December 2020

Corticotropin-releasing factor receptor type 1 mediates stress-induced relapse to cocaine-conditioned place preference in rats

1 reference

12 December 2020

Attenuation of fear conditioning by antisense inhibition of brain corticotropin releasing factor-2 receptor.

1 reference

12 December 2020

Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor

1 reference

12 December 2020

Corticotropin-releasing hormone in depression and post-traumatic stress disorder

1 reference

12 December 2020

Performance-enhancing effects of CRF-BP ligand inhibitors.

1 reference

12 December 2020

The effects of CRA 1000, a non-peptide antagonist of corticotropin-releasing factor receptor type 1, on adaptive behaviour in the rat.

1 reference

12 December 2020

Expression of corticotropin-releasing hormone type 1 receptor in paraventricular nucleus after acute stress.

1 reference

12 December 2020

Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor

1 reference

12 December 2020

Role of brain arachidonic acid cascade on central CRF1 receptor-mediated activation of sympatho-adrenomedullary outflow in rats

1 reference

12 December 2020

Long-term, progressive hippocampal cell loss and dysfunction induced by early-life administration of corticotropin-releasing hormone reproduce the effects of early-life stress.

1 reference

12 December 2020

Involvement of the hypothalamus-pituitary-adrenal axis in antidepressant activity of corticotropin-releasing factor subtype 1 receptor antagonists in the rat learned helplessness test.

1 reference

12 December 2020

Learned helplessness in the rat

1 reference

12 December 2020

Involvement of corticotropin-releasing factor subtype 1 receptor in the acquisition phase of learned helplessness in rats.

1 reference

12 December 2020

Anxiolytic properties of the selective, non-peptidergic CRF(1) antagonists, CP154,526 and DMP695: a comparison to other classes of anxiolytic agent

1 reference

12 December 2020

Corticotropin-releasing hormone promotes blastocyst implantation and early maternal tolerance

1 reference

12 December 2020

Neuroprotective effects of the CRF1 antagonist R121920 after permanent focal ischemia in the rat.

1 reference

12 December 2020

Divergent effects of corticotropin releasing hormone on endothelial cell nitric oxide synthase are associated with different expression of CRH type 1 and 2 receptors

1 reference

12 December 2020

Peripheral urocortin inhibits gastric emptying and food intake in mice: differential role of CRF receptor 2.

1 reference

12 December 2020

Effects of SR48968, a selective non-peptide NK2 receptor antagonist on emotional processes in rodents

1 reference

12 December 2020

Effects of CP-154,526 on responding during extinction from cocaine self-administration in rats

1 reference

12 December 2020

Human urocortin II, a new CRF-related peptide, displays selective CRF(2)-mediated action on gastric transit in rats

1 reference

12 December 2020

Urocortin, but not urocortin II, protects cultured hippocampal neurons from oxidative and excitotoxic cell death via corticotropin-releasing hormone receptor type I

1 reference

12 December 2020

Corticotropin-releasing hormone induces Fas ligand production and apoptosis in PC12 cells via activation of p38 mitogen-activated protein kinase

1 reference

12 December 2020

Brain pharmacokinetics of a nonpeptidic corticotropin-releasing factor receptor antagonist

1 reference

12 December 2020

Peripheral corticotropin-releasing factor induces diarrhea in rats: role of CRF1 receptor in fecal watery excretion

1 reference

12 December 2020

The CRF peptide family and their receptors: yet more partners discovered

1 reference

12 December 2020

Up-regulation of nitric oxide synthase and modulation of the guanylate cyclase activity by corticotropin-releasing hormone but not urocortin II or urocortin III in cultured human pregnant myometrial cells

1 reference

12 December 2020

4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine hydrochloride (SSR125543A): a potent and selective corticotrophin-releasing factor(1) receptor antagonist. I. Bi

1 reference

12 December 2020

4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II.

1 reference

12 December 2020

Effects of a non-peptide CRF antagonist (DMP696) on the behavioral and endocrine sequelae of maternal separation.

1 reference

12 December 2020

Differential actions of peripheral corticotropin-releasing factor (CRF), urocortin II, and urocortin III on gastric emptying and colonic transit in mice: role of CRF receptor subtypes 1 and 2.

1 reference

12 December 2020

Brain penetrance, receptor occupancy and antistress in vivo efficacy of a small molecule corticotropin releasing factor type I receptor selective antagonist

1 reference

12 December 2020

Hormonal responses to fighting in hamsters: separation of physical and psychological causes

1 reference

12 December 2020

Attenuation of corticotropin releasing factor-induced hypotension in anesthetized rats with the CRF antagonist, α-helical CRF9–41; Comparison with effect on ACTH release

1 reference

12 December 2020

Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action.

1 reference

12 December 2020

Effects of centrally administered corticotropin-releasing factor (CRF) and alpha-helical CRF on the vocalizations of isolated guinea pig pups

1 reference

12 December 2020

Noradrenergic mediation of the memory-enhancing effect of corticotropin-releasing factor in the locus coeruleus of rats

1 reference

12 December 2020

The role of the amygdala in fear-potentiated startle: implications for animal models of anxiety

1 reference

12 December 2020

N-methyl-D-aspartate lesions of the lateral and basolateral nuclei of the amygdala block fear-potentiated startle and shock sensitization of startle

1 reference

12 December 2020

Conditioned responses to cocaine-related stimuli in cocaine abuse patients.

1 reference

12 December 2020

Corticotropin-releasing hormone excites myenteric neurons in the guinea-pig small intestine

1 reference

12 December 2020

Acute and repeated exposure to social conflict in male golden hamsters: increases in plasma POMC-peptides and cortisol and decreases in plasma testosterone.

1 reference

12 December 2020

Peripherally administered CRH suppresses the vocalizations of isolated guinea pig pups

1 reference

12 December 2020

Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy. Corticotrophin-releasing factor, beta-endorphin and somatostatin

1 reference

12 December 2020

Physiology and pharmacology of corticotropin-releasing factor

1 reference

12 December 2020

Corticotropin releasing factor antagonist reduces ischemic hippocampal neuronal injury

1 reference

12 December 2020

Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo.

1 reference

12 December 2020

Interactions of corticotropin-releasing factor with antidepressant and anxiolytic drugs: behavioral studies with pigeons.

1 reference

12 December 2020

Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?

1 reference

12 December 2020

CRF antagonist reverses the "anxiogenic" response to ethanol withdrawal in the rat.

1 reference

12 December 2020

Effects of social conflict on POMC-derived peptides and glucocorticoids in male golden hamsters

1 reference

12 December 2020

Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus

1 reference

12 December 2020

Corticotrophin-releasing factor-like immunoreactivity and mRNA in human leukocytes.

1 reference

12 December 2020

Potentiation of acoustic startle by corticotropin-releasing factor (CRF) and by fear are both reversed by alpha-helical CRF (9-41).

1 reference

12 December 2020

CRF and restraint-stress decrease exploratory behavior in hypophysectomized mice.

1 reference

12 December 2020

Central administration of corticotropin releasing factor alters rat pup isolation calls

1 reference

12 December 2020

Corticotropin-releasing factor modulates defensive-withdrawal and exploratory behavior in rats

1 reference

12 December 2020

Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims

1 reference

12 December 2020

Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat.

1 reference

12 December 2020

Mediation by corticotropin releasing factor (CRF) of adenohypophysial hormone secretion

1 reference

12 December 2020

Corticotropin-releasing factor has an anxiogenic action in the social interaction test.

1 reference

12 December 2020

Corticotropin releasing factor (CRF) receptor antagonist blocks activating and 'anxiogenic' actions of CRF in the rat.

1 reference

12 December 2020

The corticotropin-releasing hormone stimulation test in patients with panic disorder.

1 reference

12 December 2020

Hypothalamic-pituitary-adrenal axis and suicide

1 reference

12 December 2020

Corticotropin-releasing factor potentiates acoustic startle in rats: blockade by chlordiazepoxide.

1 reference

12 December 2020

ICV-CRH alters stress-induced freezing behavior without affecting pain sensitivity.

1 reference

12 December 2020

Activating and 'anxiogenic' effects of corticotropin releasing factor are not inhibited by blockade of the pituitary-adrenal system with dexamethasone

1 reference

12 December 2020

A 2.5-year follow-up of depression, life crises, and treatment effects on abstinence among opioid addicts

1 reference

12 December 2020

Chlordiazepoxide attenuates response suppression induced by corticotropin-releasing factor in the conflict test

1 reference

12 December 2020

Dissociation of two components of rat behaviour by psychotropic drugs. Utilization for studying anxiolytic drugs

1 reference

12 December 2020

A simple and reliable conflict procedure for testing anti-anxiety agents

1 reference

12 December 2020

A new method for rapid screening of minor tranquillizers in mice.

1 reference

12 December 2020

Reversal of learned helplessness by imipramine

1 reference

12 December 2020

Behavioral despair in mice: a primary screening test for antidepressants

1 reference

12 December 2020

ACTH and multisteroid responses to corticotropin-releasing factor in depressive illness: Relationship to multisteroid responses after ACTH stimulation and dexamethasone suppression☆

1 reference

12 December 2020

Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines

1 reference

12 December 2020

Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin

1 reference

12 December 2020

Synthetic Competitive Antagonists of Corticotropin-Releasing Factor: Effect on ACTH Secretion in the Rat

1 reference

12 December 2020

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

1 reference

12 December 2020

The validity of animal models of depression

1 reference

12 December 2020

Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus.

1 reference

12 December 2020

Corticotropin-releasing factor (CRF): central effects on mean arterial pressure and heart rate in rats

1 reference

12 December 2020

Corticotropin releasing factor produces behavioural activation in rats.

1 reference

12 December 2020

Corticotrophin releasing factor, grooming and ingestive behavior

1 reference

12 December 2020

Specificity of the learned helplessness model of depression.

1 reference

12 December 2020

Conditioned and unconditional components of post-shock freezing.

1 reference

12 December 2020

Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression

1 reference

12 December 2020

Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease

1 reference

12 December 2020

Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor

1 reference

12 December 2020

Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor

1 reference

12 December 2020

CRF2 alpha and CRF2 beta receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues

1 reference

12 December 2020

Identification of a novel murine receptor for corticotropin-releasing hormone expressed in the heart

1 reference

12 December 2020

Corticotropin-releasing factor modulation of the ultrasonic vocalization rate of isolated rat pups

1 reference

12 December 2020

Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis.

1 reference

12 December 2020

Effect of corticotropin-releasing factor on prostaglandin synthesis in endothelial cells and fibroblasts

1 reference

12 December 2020

5-HT1A agonists modulate mouse antipredator defensive behavior differently from the 5-HT2A antagonist pirenperone

1 reference

12 December 2020

Link between emotional memory and anxiety states: a study by principal component analysis.

1 reference

12 December 2020

Expression cloning of a human corticotropin-releasing-factor receptor

1 reference

12 December 2020

Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart

1 reference

12 December 2020

A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle

1 reference

12 December 2020

Brain corticotropin-releasing factor mediates 'anxiety-like' behavior induced by cocaine withdrawal in rats

1 reference

12 December 2020

Corticotrophin-releasing factor antagonist inhibits neuronal damage induced by focal cerebral ischaemia or activation of NMDA receptors in the rat brain

1 reference

12 December 2020

The role of corticotropin-releasing factor in the anxiogenic effects of ethanol withdrawal

1 reference

12 December 2020

Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain.

1 reference

12 December 2020

Stress, antidepressant drugs, and the locus coeruleus

1 reference

12 December 2020

Characterization of a novel and potent corticotropin-releasing factor antagonist in rats.

1 reference

12 December 2020

Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor

1 reference

12 December 2020

Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors

1 reference

12 December 2020

Role of CRF in stress-related alterations of gastric and colonic motor function

1 reference

12 December 2020

Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain.

1 reference

12 December 2020

Neuroprotection by corticotropin releasing factor during hypoxia in rat brain.

1 reference

12 December 2020

Corticotropin-releasing factor: an antireproductive hormone of the testis

1 reference

12 December 2020

Synthesis and relative potencies of new constrained CRF antagonists

1 reference

12 December 2020

Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal.

1 reference

12 December 2020

Fluoxetine treatment of depression caused by interferon-alpha.

1 reference

12 December 2020

The central role of corticotrophin-releasing factor (CRF-41) in psychological stress in rats

1 reference

12 December 2020

Cloning and characterization of the human corticotropin-releasing factor-2 receptor complementary deoxyribonucleic acid

1 reference

12 December 2020

Behavioral, neurochemical, and immunological responses to CRF administration. Is CRF a mediator of stress?

1 reference

12 December 2020

CRH overproduction in transgenic mice: behavioral and immune system modulation

1 reference

12 December 2020

Unidirectional specific and modulated brain to blood transport of corticotropin-releasing hormone.

1 reference

12 December 2020

Serotonergic activation reduces defensive freezing in the conditioned fear paradigm.

1 reference

12 December 2020

CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.

1 reference

12 December 2020

A non peptidic corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like activity

1 reference

12 December 2020

Design and synthesis of a series of non-peptide high-affinity human corticotropin-releasing factor1 receptor antagonists

1 reference

12 December 2020

Differential regulation of corticotropin-releasing factor1 receptor expression by stress and agonist treatments in brain and cultured cells

1 reference

12 December 2020

In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation

1 reference

12 December 2020

Reduction of guinea pig pup isolation calls by anxiolytic and antidepressant drugs

1 reference

12 December 2020

Stress reinstates cocaine-seeking behavior after prolonged extinction and a drug-free period.

1 reference

12 December 2020

Corticotropin-releasing factor receptor antagonist infused into the locus coeruleus attenuates immobilization stress-induced defensive withdrawal in rats.

1 reference

12 December 2020

Alpha-helical CRF blocks differential influence of corticotropin releasing factor (CRF) on appetitive and aversive memory retrieval in rats.

1 reference

12 December 2020

Astressin, a novel and potent CRF antagonist, is neuroprotective in the hippocampus when administered after a seizure

1 reference

12 December 2020

CRH and the immune system

1 reference

12 December 2020

Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats.

1 reference

12 December 2020

Presence of functional receptors for corticotropin releasing hormone in caecal circular smooth muscle cells of guinea pig.

1 reference

12 December 2020

Olfactory bulb ablation in the rat: behavioural changes and their reversal by antidepressant drugs

1 reference

12 December 2020

Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist.

1 reference

12 December 2020

Neurobiology of corticotropin releasing factor (CRF) receptors and CRF-binding protein: implications for the treatment of CNS disorders

1 reference

12 December 2020

Synthesis and oral efficacy of a 4-(butylethylamino)pyrrolo[2,3-d]pyrimidine: a centrally active corticotropin-releasing factor1 receptor antagonist.

1 reference

12 December 2020

Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal

1 reference

12 December 2020

Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects.

1 reference

12 December 2020

Labelling of CRF1 and CRF2 receptors using the novel radioligand, [3H]-urocortin

1 reference

12 December 2020

Chronic effects of a nonpeptide corticotropin-releasing hormone type I receptor antagonist on pituitary-adrenal function, body weight, and metabolic regulation.

1 reference

12 December 2020

Pharmacological characterisation of the recombinant human CRF binding protein using a simple assay.

1 reference

12 December 2020

Central CRF inhibits gastric emptying of a nutrient solid meal in rats: the role of CRF2 receptors.

1 reference

12 December 2020

Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1.

1 reference

12 December 2020

CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats.

1 reference

12 December 2020

A corticotropin-releasing hormone type I receptor antagonist delays parturition in sheep

1 reference

12 December 2020

The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats.

1 reference

12 December 2020

Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome

1 reference

12 December 2020

Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone.

1 reference

12 December 2020

Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: the CRF2gamma receptor

1 reference

12 December 2020

ICV administration of CRF blocker (CRF9-41 delta helical) reduces morphine withdrawal in rats

1 reference

12 December 2020

Evidence for the involvement of corticotrophin-releasing hormone in the pathogenesis of traumatic brain injury.

1 reference

12 December 2020

Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30

1 reference

12 December 2020

The Impact of the Nonpeptide Corticotropin-Releasing Hormone Antagonist Antalarmin on Behavioral and Endocrine Responses to Stress1

1 reference

12 December 2020

In vitro excitatory actions of corticotropin-releasing factor on rat colonic motility

1 reference

12 December 2020

In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation

1 reference

12 December 2020

The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress

1 reference

12 December 2020

10.1111/J.1527-3458.2003.TB00244.X

Identifiers

DOI

0 references

0 references

1 reference